Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Report card on cervical cancer prevention underscores importance of HPV testing
February 20th, 2005
According to a new report, top performing states in cervical cancer prevention all reimburse for U.S. Food and Drug Administration-approved human papillomavirus (HPV) testing for routine screening through their Medicaid programs. The recognition of HPV testing as an indicator of success in the Women In Government report, "A Call to Action: the 'State' of Cervical Cancer Prevention in America," underscores the test's growing importance from a public health perspective. "Our report shows that states that are the most successful have higher screening rates, cover advanced screening technology - particularly HPV testing - in their public insurance...
Source: Medical Letter on the CDC & FDA (2005-02-20)
|
